Fish consumption and the risk of islet autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) Study

This abstract has open access
Abstract Summary

 

Background

 

In TEDDY fish-derived fatty acid status during childhood was inversely associated with the risk of islet autoimmunity (IA). The current study aimed to examine the association of fish consumption with the risk of IA as well as IAA only and GADA only as the first appearing autoantibody during the first 5 years of life.

 

Methods

 

TEDDY is a longitudinal cohort study of children at high genetic risk for T1DM (n=8 676) born between 2004-2010 in Germany, Finland, Sweden and the US. Food consumption was studied by 3-day food records at the age of 6, 9 and 12 months and thereafter biannually. We included 8474 subjects in the analysis, after exclusions for HLA ineligibility (n=120), indeterminate autoantibody (n=55) and missing food records (n=27). During the first 5 years of life, 542 (6.4%) children developed persistent confirmed IA, with 240 (2.8%) having IAA only and 199 (2.3%) GADA only as the first appearing autoantibody. The median (IQR) age at clinical onset was 24 (13-39) months for persistent confirmed IA, 18 (10-31) months for IAA only and 31 (18-46) months for GADA only. Time-dependent Cox proportional hazard regression was used to analyze the association with adjustment for HLA-genotype, FDR status, sex, and country (as strata).

 

Results

 

The proportion of children reported to consume fish during the 3 recording days increased from 0% at 3 months to 32% at 12 months, remaining about 40% from the age of 18 months. Fish consumption was associated with lower risk of IA (HR 0.75, 95% CI 0.61-0.93, p=0.010). In smaller subsets, fish consumption tended to reduce the risk of IAA only (HR 0.73, 95% CI 0.54-1.00, p=0.052) but not GADA only (HR 0.77, 95% CI 0.54-1.10, p=0.150) as the first appearing autoantibody.

 

 

Conclusion

 

Fish consumption might protect against IA in children genetically susceptible to T1DM.

 

Submission ID :
IDS91113
Submission Type
Abstract Topics
National Instute for Health and Welfare
Pacific Northwest Diabetes Research Institute, USA
University of Turku
Lund University, Lund (Sweden)
Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany
Barbara Davis Center
National Institute of Diabetes and Digestive and Kidney Diseases
University of South Florida, USA
Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, United States
Center for Public Health Genomics University of Virginia, United States
Lund University, Sweden
Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, United States
Health Informatics Institute, University of South Florida
Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland
Department of Clinical Sciences, Lund University/CRC, Skåne University Hospital, Malmö, Sweden
Institute of Diabetes Research, Helmholtz Zentrum München and Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München and Forschergruppe Diabetes e.V., Munich, Germany
University of Tampere, Faculty of Social Sciences/Health, University of Tampere, Tampere, Finland
Medical College of Georgia, Georgia Regents University, Augusta, Georgia, United States
Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, United States
University of Helsinki

Abstracts With Same Type

Submission ID
Submission Title
Submission Topic
Submission Type
Primary Author
4 visits

KEY DATES

Event dates:
Thursday 25 October - Monday 29 October 2018

Abstract submission deadline:
Monday 14 May 2018

Abstract notification:
July 2018

Early registration deadline:
Monday 3 September 2018

Registration deadline:
Monday 15 October 2018

Contact
British Society for Immunology
+44 (0)20 3019 5901
congress@immunology.org